TABLE 3

pEC50 and Emax values derived from concentration-response curves to the sGC stimulators BAY 41-2272 (0.0001–1 μM) and YC-1 (0.001–30 μM) in endothelium-intact mesenteric artery rings contracted with phenylephrine (1 μM)

Curves were performed in the absence and in the presence of the Akt inhibitor (10 μM; n = 4) or the PKG inhibitors KT 5823 (1 μM; n = 4), Rp-8-pCPT-cGMPS (30 μM; n = 4), and DT-3 (1 μM; n = 4). Data represent the means ± S.E.M. of n experiments.



BAY 41-2272

YC-1

pEC50
Emax
pEC50
Emax
Control 8.20 ± 0.06 95 ± 3 6.70 ± 0.04 95 ± 3
+ Akt inhibitor 8.11 ± 0.05 93 ± 2 6.61 ± 0.05 91 ± 4
Control 8.08 ± 0.04 91 ± 5 6.79 ± 0.06 93 ± 4
+ KT 5823 8.20 ± 0.04 91 ± 6 6.68 ± 0.06 97 ± 2
Control 8.28 ± 0.05 91 ± 8 6.64 ± 0.08 97 ± 2
+ Rp-8-pCPT-cGMPS 8.14 ± 0.05 86 ± 7 6.58 ± 0.07 93 ± 3
Control 8.20 ± 0.06 95 ± 3 6.73 ± 0.05 94 ± 3
+ DT-3
8.06 ± 0.07
92 ± 5
6.59 ± 0.05
91 ± 4